# Avista Pharma Solutions, Inc. dba Cambrex – FDA Inspection, Jul 3, 2025

Source: https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/8a4208ef-dcad-47c0-9bbd-2ab3cdc26b19
Source feed: FDA_Inspections

> FDA inspection 1277419 of Avista Pharma Solutions, Inc. dba Cambrex, July 03, 2025. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1277419
- Company Name: Avista Pharma Solutions, Inc. dba Cambrex
- Inspection Date: 2025-07-03
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Atlanta District Office
- Citation Count: 0

## Related Documents

- [FDA Inspection 1128465 - 2020-07-17](https://www.keypedia.com/records/fda_inspections/avista-pharma-solutions-inc-dba-cambrex/ee45f26b-b044-435f-9d45-4363448c47de)
- FDA Inspection 805222 - 2012-10-30
- FDA Inspection 636454 - 2009-10-09

## Related Officers

- [Company Rep](https://www.keypedia.com/people/daveta-l-bailey/b3c06872-638b-4c47-9539-a93b819be23f)

Company: https://www.keypedia.com/companies/avista-pharma-solutions-inc-dba-cambrex/56214bca-3cc9-496a-a019-aab43c351824

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7